Literature DB >> 560884

Lithium inhibition of norepinephrine and dopamine receptors.

A Flemenbaum.   

Abstract

Sprague-Dawley rats (150-200 g), serving as their own controls, were evaluated for hyperactivity (HyA) and stereotyped behavior (SB) produced by chronic (1 week) ip administration of different doses of drugs that have differential NE and DA " agonist" properties. Drugs utilized were d- and l-amphetamine, metamphetamine, cocaine, and the specific and direct DA receptor agonist apomorphine. This was followed by 1 week of rest after which all rats received 3 weeks of lithium chloride (Li) subcutaneously. In the last week of Li administration, each rat also was given the same drug administered previously at the same dose. In all cases, Li decreased both HyA and SB, suggesting Li effects both at the pre- and postsynaptic neuron (receptor).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 560884

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Lithium administration antagonizes cholinergic behavioral effects in rodents.

Authors:  D S Janowsky; A A Abrams; G P Groom; L L Judd; P Cloptin
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

2.  Effect of lithium carbonate on memory processes of bipolar affectively ill patients.

Authors:  V I Reus; S D Targum; H Weingarter; R M Post
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

Review 3.  Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

4.  The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.

Authors:  E H Rubin; G F Wooten
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats.

Authors:  U Berggren
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 6.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

7.  Changes in blood plasma osmolality and states of mania.

Authors:  C F Baxter; K H Tachiki; S M Blaser; B R Bednar; L F Gosenfeld
Journal:  Neurochem Res       Date:  1981-01       Impact factor: 3.996

8.  Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.

Authors:  D P van Kammen; J P Docherty; S R Marder; J E Rosenblatt; W E Bunney
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

Authors:  Jean-Martin Beaulieu; Tatyana D Sotnikova; Wei-Dong Yao; Lisa Kockeritz; James R Woodgett; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

10.  Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible animal model for mania.

Authors:  A L Vale; F Ratcliffe
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.